Veracyte, Inc. (VCYT) Q2 2026 Earnings Call July 30, 2026 4:30 PM EDT
Company Participants
Kelly Gura – Director of Investor Relations
Marc Stapley – CEO & Director
Rebecca Chambers – Executive VP & CFO
John Leite – Global Chief Commercial Officer
Conference Call Participants
Keith Hinton – Prime Executions, Inc., Research Division
Jacob Dodd
Puneet Souda – Leerink Partners LLC, Research Division
Mason Carrico – Stephens Inc., Research Division
Joseph Conway – Needham & Company, LLC, Research Division
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Veracyte Second Quarter 2026 Financial Results Webcast, [Operator Instructions]. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Kelly Gura, Director of Investor Relations. Please go ahead.
Kelly Gura
Director of Investor Relations
Good afternoon, everyone, and thank you for joining us today to review Veracyte’s Second Quarter 2026 Financial Results. Joining me on the call are Marc Stapley, our Chief Executive Officer; and Rebecca Chambers, our Chief Financial Officer. Dr. John Leite, our Chief Commercial Officer, will also be available for Q&A.
Earlier this afternoon, we issued a press release detailing our second quarter financial results, and we posted an accompanying presentation in the Investors section of our website. Before we begin, I’d like to remind you that statements we make during this call will include forward-looking statements as defined under applicable securities laws. Forward-looking statements are subject to risks and uncertainties, and the company can give no assurance that they will prove to be correct. The company undertakes no obligation to update any forward-looking statements, except as required by law. To better understand the risks and uncertainties that could cause actual results to differ, we refer you to the documents that Veracyte files with the Securities and Exchange Commission, including the most recent Forms 10-Q and 10-K.
